HR 7867
Infant Formula Safety Modernization Act of 2026
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 2:37 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Infant Formula Safety Modernization Act of 2026 aims to improve the safety of infant formula by requiring standardized testing for pathogens and microorganisms in both manufacturing facilities and finished products. It mandates that manufacturers notify the FDA of any positive test results within 24 hours and establishes clear inspection standards for all infant formula, regardless of where it’s produced. The bill also requires the FDA to notify Congress of positive test results and inspection classifications, increasing transparency and accountability.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.